Aprea Therapeutics, Inc.

NasdaqCM:APRE Stock Report

Market Cap: US$15.8m

Aprea Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:APRE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Oct 24BuyUS$1,958Oren GiladIndividual500US$3.92
18 Oct 24SellUS$29,583Marc DueyIndividual6,462US$4.58
16 Oct 24BuyUS$131,700Marc DueyIndividual30,000US$4.39
15 Oct 24BuyUS$725Oren GiladIndividual250US$2.90
14 Oct 24BuyUS$2,971Oren GiladIndividual1,150US$2.59
14 Oct 24BuyUS$490Marc DueyIndividual190US$2.58
11 Oct 24BuyUS$26,800Bernd SeizingerIndividual10,000US$2.68
11 Oct 24BuyUS$123John HamillIndividual50US$2.46
10 Oct 24BuyUS$1,175John HamillIndividual450US$2.61
13 Mar 24BuyUS$7,363John HamillIndividual1,010US$7.29
13 Mar 24BuyUS$50,009John HennemanIndividual6,860US$7.29
13 Mar 24BuyUS$14,580Oren GiladIndividual2,000US$7.29
13 Mar 24BuyUS$50,009Bernd SeizingerIndividual6,860US$7.29

Insider Trading Volume

Insider Buying: APRE insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of APRE?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds276,6035.09%
VC/PE Firms539,3009.92%
Individual Insiders638,73311.8%
Institutions1,609,37429.6%
General Public2,370,89343.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 45.4%.


Top Shareholders

Top 25 shareholders own 56.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.92%
Aigh Capital Management, LLC
539,300US$1.6m0%0.75%
5.96%
Oren Gilad
324,115US$943.2k1.12%no data
5.09%
Sio Capital Management, LLC
276,603US$804.9k0%0.38%
4.97%
Sphera Funds Management Ltd
270,000US$785.7k0%0.13%
4.29%
Marc Duey
233,208US$678.6k11.4%no data
4.2%
Stonepine Capital Management LLC
228,262US$664.2k66.4%0.22%
3.79%
Nantahala Capital Management, LLC
205,760US$598.8k0%0.04%
3.79%
Dellora Investments LP
205,760US$598.8k0%no data
3.2%
The Vanguard Group, Inc.
173,842US$505.9k50.1%no data
2.52%
Dafna Capital Management, LLC
137,174US$399.2k0%0.1%
2.52%
Exome Asset Management LLC
137,174US$399.2k0%0.27%
2.34%
Farringdon Capital Management
127,070US$369.8k0%0.29%
0.8%
Bernd Seizinger
43,685US$127.1k31.6%no data
0.74%
Geode Capital Management, LLC
40,067US$116.6k12.3%no data
0.63%
Morgan Stanley, Investment Banking and Brokerage Investments
34,208US$99.5k14.7%no data
0.31%
Dimensional Fund Advisors LP
17,064US$49.7k54.1%no data
0.31%
Rifat Pamukcu
16,964US$49.4k0%no data
0.26%
HighTower Advisors, LLC
13,864US$40.3k0%no data
0.16%
BlackRock, Inc.
8,504US$24.7k0%no data
0.14%
John Henneman
7,639US$22.2k0%no data
0.13%
John Hamill
7,008US$20.4k7.7%no data
0.078%
Scott Coiante
4,213US$12.3k0%no data
0.06%
Merrill Lynch & Co. Inc., Banking Investments
3,250US$9.5k0%no data
0.04%
Group One Trading LP, Asset Management Arm
2,160US$6.3k0%no data
0.029%
Bank of America Corporation, Asset Management Arm
1,602US$4.7k-0.06%no data